Status:

COMPLETED

Saliva Testosterone Increases in Irritable Bowel Syndrome (IBS) Patients Beginning Choir Singing

Lead Sponsor:

Stockholm University

Collaborating Sponsors:

The Swedish Research Council

Region Stockholm

Conditions:

Irritable Bowel Syndrome

Eligibility:

All Genders

Phase:

NA

Brief Summary

The hypothesis was that a one-year experience of choir singing once a week is more beneficial than group discussions to saliva concentration of testosterone.

Detailed Description

The project aimed to study the health effects of regular choir singing for persons who are in a psychosomatic condition (Irritable Bowel syndrome - IBS). A group of IBS patients were randomized to cho...

Eligibility Criteria

Inclusion

  • IBS according to physician certificates.
  • Wish to start choir singing but no such experience during past ten years.
  • Acceptance of randomisation condition.

Exclusion

  • No serious somatic diseases.
  • No abuse of alcohol or drugs.
  • No ongoing acute psychiatric condition.

Key Trial Info

Start Date :

May 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2007

Estimated Enrollment :

55 Patients enrolled

Trial Details

Trial ID

NCT00931294

Start Date

May 1 2006

End Date

May 1 2007

Last Update

July 2 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stockholm, Sweden

Saliva Testosterone Increases in Irritable Bowel Syndrome (IBS) Patients Beginning Choir Singing | DecenTrialz